{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "82576-060",
      "generic_name": "Resmetirom",
      "labeler_name": "Madrigal Pharmaceuticals, Inc.",
      "brand_name": "REZDIFFRA",
      "active_ingredients": [
        {
          "name": "RESMETIROM",
          "strength": "60 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "82576-060-30",
          "description": "30 TABLET, COATED in 1 BOTTLE (82576-060-30)",
          "marketing_start_date": "20240314",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Madrigal Pharmaceuticals, Inc."
        ],
        "rxcui": [
          "2677899",
          "2677905",
          "2677907",
          "2677909",
          "2677911",
          "2677913"
        ],
        "spl_set_id": [
          "e67ea09f-a840-439c-86c8-f98585f978b2"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0382576060306"
        ],
        "nui": [
          "N0000194131",
          "N0000194132",
          "N0000187062",
          "N0000190107",
          "N0000190108",
          "N0000190113"
        ],
        "pharm_class_epc": [
          "Thyroid Hormone Receptor beta Agonist [EPC]"
        ],
        "pharm_class_moa": [
          "Thyroid Hormone Receptor beta Agonists [MoA]",
          "Cytochrome P450 2C8 Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]"
        ],
        "unii": [
          "RE0V0T1ES0"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, COATED",
      "spl_id": "1fec1a4b-28d9-41c3-ae32-59b53cd41f07",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20240314",
      "product_id": "82576-060_1fec1a4b-28d9-41c3-ae32-59b53cd41f07",
      "application_number": "NDA217785",
      "brand_name_base": "REZDIFFRA",
      "pharm_class": [
        "Breast Cancer Resistance Protein Inhibitors [MoA]",
        "Cytochrome P450 2C8 Inhibitors [MoA]",
        "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
        "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
        "Thyroid Hormone Receptor beta Agonist [EPC]",
        "Thyroid Hormone Receptor beta Agonists [MoA]"
      ]
    }
  ]
}